Recent Advances in Innovative Magnetic Nanomaterials for Cancer Theranostics

Sudip Mukherjee is a postdoctoral research associate at the department of bioengineering at Rice University. His research involves in the development of advanced nano/bio materials for drug delivery in cancer theranostics, immunomodulatory applications in cancer and diabetes, and angiogenesis. He has published more than 36 peer-reviewed research articles, three book chapters and three patents. He serves as an international advisory board member of Materials Research Express journal and also works as a scientific blog writer for RSC's Biomaterials Science.

Table of Contents


Chapter 1: Introduction


1.1.        Cancer and
statistics


1.2.        Conventional
therapies for cancer and their limitations


1.3.        Alternative
theranostics strategy: Nanomedicine


1.4.        Magnetic
nanoparticles and cancer theranostics


Chapter 2: Magnetic nanoparticles: Types, synthesis and
characterization


2.1          Common types of
magnetic nanomaterials and their synthesis


2.2          Characterization
techniques


2.3          Multilayer concept


Chapter 3: Magnetic nanoparticles for cancer diagnostics


3.1.        MRI


3.2.        Multimodal imaging


3.3.        Biosensors


3.4.        Cell labeling


Chapter 4: Magnetic nanoparticles for cancer therapeutics


4.1.        Drug delivery:
Chemotherapeutics, Biotherapeutics and Radiotherapeutics


4.2.        Magnetic
Hyperthermia


4.3.        Photodynamic therapy



4.4.        Photothermal
ablation


4.5.        MNPs as Anticancer
agent


4.6.        MNPs in Cancer
Immunotherapy


Chapter 5: Safety of Magnetic nanomaterials, Challenges, future scope
and Conclusion 


5.1.        Pharmacokinetics, biodistribution,
toxicity


5.2.        Targeting


5.3.        Magnetic
nanoparticles as FDA approved or in clinical trials


5.4.        Challenges, future
scopes and conclusion